The results found that Duvelisib could regulate lung fibroblasts proliferation, migration, activation and autophagy by inhibiting the PI3K/Akt/mTOR signalling pathway, thereby attenuating pulmonary fibrosis. Here, AKT1 is linked to pulmonary fibrosis.